Burchardt, N. A., Eliassen, A. H., Shafrir, A. L., Rosner, B., Tamimi, R. M., Kaaks, R., . . . Fortner, R. T. (2022). Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: A prospective cohort study. American journal of obstetrics and gynecology, 226(6), . https://doi.org/10.1016/j.ajog.2021.12.022
Chicago Style (17th ed.) CitationBurchardt, Norah Ana, A. Heather Eliassen, Amy L. Shafrir, Bernard Rosner, Rulla M. Tamimi, Rudolf Kaaks, Shelley S. Tworoger, and Renée T. Fortner. "Oral Contraceptive Use by Formulation and Breast Cancer Risk by Subtype in the Nurses' Health Study II: A Prospective Cohort Study." American Journal of Obstetrics and Gynecology 226, no. 6 (2022). https://doi.org/10.1016/j.ajog.2021.12.022.
MLA (9th ed.) CitationBurchardt, Norah Ana, et al. "Oral Contraceptive Use by Formulation and Breast Cancer Risk by Subtype in the Nurses' Health Study II: A Prospective Cohort Study." American Journal of Obstetrics and Gynecology, vol. 226, no. 6, 2022, https://doi.org/10.1016/j.ajog.2021.12.022.